Interleukin Genetics Presents Research Linking Vertebral Fractures To Gene Variations In Asian Women With Osteoporosis

Interleukin Genetics, Inc. (NYSE Amex: ILI), announced that the company will present research findings from a large clinical study on the genetics of osteoporosis and vertebral fractures at the 8th International Symposium on Osteoporosis: Translating Research into Clinical Practice, on April 4, 2009 at the Marriott Wardman Park Hotel in Washington, D.C.

More: continued here

Filed under: Bones on April 3rd, 2009